WVP
ANIP icon

Worth Venture Partners’s ANI Pharmaceuticals ANIP Stock Holding History

Worth Venture Partners’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-26,000
Closed -$10K – 106
2017
Q4 		$10K Buy
26,000
+6,300
+32% +$392K 0.01% 98
2017
Q3 		$18K Buy
19,700
+3,000
+18% +$143K 0.02% 113
2017
Q2 		$8K Sell
16,700
-8,000
-32% -$386K 0.01% 107
2017
Q1 		$4K Buy
24,700
+16,200
+191% +$910K ﹤0.01% 132
2016
Q4 		$7K Buy
+8,500
New +$520K 0.01% 117

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Worth Venture Partners's ANIP Position: Q3 2023 in Review

Worth Venture Partners sold out of ANI Pharmaceuticals (ANIP) in Q3 2023, closing a stake of 87,472 shares — an estimated $4.71M sold.

Worth Venture Partners first reported a position in ANIP in Q2 2022 and held it in 5 quarters. The position peaked at $4.71M in Q2 2023. 186 funds tracked by Wall St. Rank hold ANIP as of Q3 2023.

  • Worth Venture Partners reported no remaining ANI Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Worth Venture Partners sold 87,472 ANI Pharmaceuticals shares in Q3 2023, an estimated $4.71M.
  • Worth Venture Partners first reported a position in ANI Pharmaceuticals in Q2 2022 and held it in 5 quarters.
  • Worth Venture Partners's ANI Pharmaceuticals position peaked at $4.71M in Q2 2023.
  • 186 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2023.

Based on Worth Venture Partners's 13F filing for Q3 2023, filed 15 Nov 2023.